Bullous pemphigoid associated with dipeptidyl peptidase‐4 inhibitor showing unfavorable outcomes despite immediate discontinuation of medication

We experienced two cases of dipeptidyl peptidase‐4 (DPP‐4) inhibitor‐associated bullous pemphigoid (BP) showing an unfavorable course despite its discontinuation. Clinicians should carefully monitor the course of DPP‐4 inhibitor‐associated BP even after withdrawal of DPP‐4 inhibitor therapy, especia...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clin Case Rep
Hlavní autoři: Shinohara, Yasutake, Iijima, Toshie, Sakurai, Shintaro, Jojima, Teruo, Ohira, Eriko, Hayashi, Shujiro, Usui, Isao, Igawa, Ken, Aso, Yoshimasa
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2020
Témata:
Case Reports
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7562854/
https://ncbi.nlm.nih.gov/pubmed/33088540
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.3047
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky